HRP20200380T1 - Pripravak koji sadrži ester alfa-tokoferola za prevenciju i liječenje alergijskog rinitisa - Google Patents

Pripravak koji sadrži ester alfa-tokoferola za prevenciju i liječenje alergijskog rinitisa Download PDF

Info

Publication number
HRP20200380T1
HRP20200380T1 HRP20200380TT HRP20200380T HRP20200380T1 HR P20200380 T1 HRP20200380 T1 HR P20200380T1 HR P20200380T T HRP20200380T T HR P20200380TT HR P20200380 T HRP20200380 T HR P20200380T HR P20200380 T1 HRP20200380 T1 HR P20200380T1
Authority
HR
Croatia
Prior art keywords
alpha
preparation
hydrogenated
use according
tocopherol
Prior art date
Application number
HRP20200380TT
Other languages
English (en)
Inventor
Giorgio Panin
Jürgen Lamprecht
Original Assignee
Bio.Lo.Ga. S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51589387&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20200380(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio.Lo.Ga. S.R.L. filed Critical Bio.Lo.Ga. S.R.L.
Publication of HRP20200380T1 publication Critical patent/HRP20200380T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Claims (7)

1. Pripravak za vanjsku primjenu, za upotrebu u prevenciji ili liječenju alergijskog rinitisa, koja se sastoji od estera alfa-tokoferola izabranog iz grupe koja se sastoji od alfa-tokoferil acetata, n-propionata i linoleata, i uljnog nosača izabranog iz grupe koja se sastoji od hidrogeniranog poliizobutena, hidrogeniranog polidecena, mješavina hidrogeniranog poliizobutena i/ili hidrogeniranog polidecena sa hidrogeniranim poliolefinima, konkretno hidrogeniranim C6-C14 hidrogeniranim poliolefinima, triglicerida kaprilne/kaprinske kiseline, biljnog ulja, ulja Adansonia digitata, ulja sjemena Adansonia digitata, kokosovog kaprilata/kaprata, skvalena masline, skvalena masline, ulja sjemena suncokreta (Heliantus annus), kokosovog kaprilata, izononil izononanoata, ciklopentasiloksana, i njihovih mješavina.
2. Pripravak za upotrebu prema patentnom zahtjevu 1, naznačen time, što navedeni pripravak sadrži 3% do 80% po težini navedenog estera alfa-tokoferola u odnosu na ukupnu težinu pripravka.
3. Pripravak za upotrebu prema patentnom zahtjevu 1, naznačen time, što navedeni pripravak sadrži 5% do 40%, poželjno 10% do 30% po težini navedenog estera alfa-tokoferola u odnosu na ukupnu težinu pripravka.
4. Pripravak za upotrebu prema bilo kojem od patentnih zahtjeva 1 do 3, naznačen time, što je navedeni ester alfa-tokoferola alfa-tokoferil acetat.
5. Pripravak za upotrebu prema bilo kojem od patentnih zahtjeva 1 do 4, naznačen time, što se navedeni uljni nosač sastoji od hidrogeniranog polidecena.
6. Pripravak za upotrebu prema patentnom zahtjevu 5, naznačen time, što je navedeni ester alfa-tokoferola alfa-tokoferil acetat.
7. Pripravak za upotrebu prema patentnom zahtjevu 6, koji se sastoji od 10-30% alfa-tokoferil acetata i 70-90% hidrogeniranog polidecena.
HRP20200380TT 2014-07-22 2020-03-06 Pripravak koji sadrži ester alfa-tokoferola za prevenciju i liječenje alergijskog rinitisa HRP20200380T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20141332 2014-07-22
EP15720286.2A EP3171873B1 (en) 2014-07-22 2015-04-17 Composition comprising an ester of alpha-tocopherol for prevention and treatment of allergic rhinitis
PCT/EP2015/058368 WO2016012110A1 (en) 2014-07-22 2015-04-17 Composition comprising an ester of alpha-tocopherol for prevention and treatment of allergic rhinitis

Publications (1)

Publication Number Publication Date
HRP20200380T1 true HRP20200380T1 (hr) 2020-08-07

Family

ID=51589387

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20200380TT HRP20200380T1 (hr) 2014-07-22 2020-03-06 Pripravak koji sadrži ester alfa-tokoferola za prevenciju i liječenje alergijskog rinitisa

Country Status (24)

Country Link
US (1) US20170165226A1 (hr)
EP (1) EP3171873B1 (hr)
CN (1) CN106659709A (hr)
AR (1) AR101274A1 (hr)
AU (1) AU2015294663B2 (hr)
BR (1) BR112017001116A8 (hr)
CA (1) CA2955664C (hr)
CL (1) CL2017000058A1 (hr)
CO (1) CO2017000550A2 (hr)
CY (1) CY1122823T1 (hr)
DE (1) DE202014106007U1 (hr)
DK (1) DK3171873T3 (hr)
EA (1) EA201692486A1 (hr)
ES (1) ES2779525T3 (hr)
HR (1) HRP20200380T1 (hr)
HU (1) HUE049588T2 (hr)
LT (1) LT3171873T (hr)
MX (1) MX369991B (hr)
PE (1) PE20170437A1 (hr)
PL (1) PL3171873T3 (hr)
PT (1) PT3171873T (hr)
RS (1) RS60103B1 (hr)
SI (1) SI3171873T1 (hr)
WO (1) WO2016012110A1 (hr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6992057B2 (ja) 2016-06-10 2022-01-13 クラリティ コスメティックス インコーポレイテッド 非面皰形成性の毛髪および頭皮ケア製剤ならびにその使用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4269835A (en) * 1979-12-13 1981-05-26 Whittle Barry J Nasal composition for relieving nasal distress
US4364945A (en) * 1979-12-13 1982-12-21 Whittle Barry J Nasal composition for relieving nasal distress
US20100055152A1 (en) * 2008-08-26 2010-03-04 Trutek Corporation Antihistamine and antihistamine-like nasal application, products, and method
DE4327089A1 (de) * 1993-08-12 1995-02-16 Roshdy Ismail Mittel zur Behandlung von allergischen Erkrankungen der Atemwege
IT1282778B1 (it) * 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
ITMI981586A1 (it) * 1998-07-10 2000-01-10 Giorgio Panin Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
JP2003128552A (ja) * 2001-08-16 2003-05-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
US20060198904A1 (en) 2002-11-20 2006-09-07 Istvan Boldogh Methods for inhibiting allergic inflammation and other responses initiated by pollens, molds, and other non-animal derived allergens
JP2008266255A (ja) * 2007-04-24 2008-11-06 Project M:Kk アレルギー性疾患を予防および/または治療するための組成物
US20100076072A1 (en) 2008-07-25 2010-03-25 Northwestern University Compositions and methods of vitamin e administration
IT1393056B1 (it) * 2008-09-22 2012-04-11 Bio Lo Ga Srl Uso di vitamina e o suoi derivati per il controllo di artropodi
ITMI20090480A1 (it) * 2009-03-27 2010-09-28 Bio Lo Ga Srl Supporto tessile imbevuto di una composizione detergente/idratante
CN103717235A (zh) * 2011-06-24 2014-04-09 埃皮托吉尼西斯有限公司 作为抗原特异性免疫调节剂的包含选择的载体、维生素、单宁和类黄酮的组合的药物组合物

Also Published As

Publication number Publication date
CA2955664C (en) 2022-09-06
PE20170437A1 (es) 2017-04-22
CA2955664A1 (en) 2016-01-28
CL2017000058A1 (es) 2017-08-11
SI3171873T1 (sl) 2020-07-31
US20170165226A1 (en) 2017-06-15
PL3171873T3 (pl) 2020-07-13
LT3171873T (lt) 2020-04-10
EP3171873A1 (en) 2017-05-31
WO2016012110A1 (en) 2016-01-28
MX2017000906A (es) 2017-05-12
AU2015294663B2 (en) 2019-11-21
ES2779525T3 (es) 2020-08-18
HUE049588T2 (hu) 2020-10-28
EA201692486A1 (ru) 2017-07-31
CY1122823T1 (el) 2021-05-05
RS60103B1 (sr) 2020-05-29
AR101274A1 (es) 2016-12-07
AU2015294663A1 (en) 2017-01-19
DK3171873T3 (da) 2020-03-16
BR112017001116A2 (pt) 2018-01-23
DE202014106007U1 (de) 2015-07-23
MX369991B (es) 2019-11-27
CN106659709A (zh) 2017-05-10
PT3171873T (pt) 2020-02-25
CO2017000550A2 (es) 2017-03-31
EP3171873B1 (en) 2019-12-25
BR112017001116A8 (pt) 2022-07-05

Similar Documents

Publication Publication Date Title
MX2019014980A (es) 3-fenilisoxazolin-5-carboxamidas de acidos y esteres tetrahidro y dihidrofuranocarboxilicos con efecto herbicida.
EA201790978A1 (ru) Способы и композиции, относящиеся к синтетическим наноносителям с рапамицином в стабильном пересыщенном состоянии
BR112015016082A2 (pt) curativo indicador de umidade
PH12014501411B1 (en) Fabric softener active composition
EA201990337A1 (ru) Композиция для местного применения с противогрибковой активностью
HRP20191989T1 (hr) Farmaceutski pripravak za uporabu u povećanju trofizma sluznice nosa
BR112015023190A2 (pt) regulação de câncer com o uso de compostos e/ou dieta naturais
FR3024037B1 (fr) Ingredient actif cosmetique ou dermatologique comprenant un melange d'acides dicarboxyliques gras insatures, compositions le comprenant et utilisations cosmetiques ou dermatologiques
EP2997958A3 (de) Formulierung enthaltend flüssige esterquats und/oder imidazoliniumsalze und polymerverdicker
AR094407A1 (es) Protección de ácido 4-amino-3-cloro-6-(4-cloro-2-flúor-3-metoxifenil)piridina-2-carboxílico y los derivados del mismo en los cultivos de cereales
CY1123942T1 (el) Συνθεσεις ωμεγα-3 λιπαρων οξεων για τη θεραπεια ασθενειων που επιφερουν βλαβη στο νευρικο συστημα
DOP2017000058A (es) Derivados de tetrahidroquinolina como inhibidores del bromodominio
HRP20200380T1 (hr) Pripravak koji sadrži ester alfa-tokoferola za prevenciju i liječenje alergijskog rinitisa
JP2016519101A5 (hr)
MY183624A (en) Transparent sunscreen compositions and use thereof
WO2014164648A3 (en) Solid state forms of a quinazoline derivative and its use as a braf inhibitor
CO7141473A2 (es) Vehículos de liberación de composiciones pesticidas
CL2017001579A1 (es) Copolímeros de polidialilamina reticulados para el tratamiento de la diabetes de tipo 2
MX2021001790A (es) Composiciones solidas de trigliceridos y usos de estas.
FR3007652B1 (fr) Composition comprenant de l'acide docosahexaenoique et du pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate
UY36227A (es) Composición para uso en la prevención y tratamiento de rinitis alérgica
WO2015123480A3 (en) Compositions and methods for the prevention and/or treatment of schistosomiasis
MY178089A (en) Glyceride composition
BR112016024753A2 (pt) produto absorvente
CL2018001806A1 (es) Composiciones cosméticas que comprenden una combinación sinérgica de partículas absorbentes y adsorbentes de sudor y usos de las mismas